4 insiders reported 122 Form 4 transactions for Nurix Therapeutics, Inc. (NRIX) over the past 18 months (most recent 2026-08-05). Recent activity: Hansen Gwenn (Chief Scientific Officer) Sell 1,500 shares, Hansen Gwenn (Chief Scientific Officer) Buy 4,356 shares, Hansen Gwenn (Chief Scientific Officer) Sell 2,611 shares, Hansen Gwenn (Chief Scientific Officer) Sell 4,356 shares, van Houte Hans (Chief Financial Officer) Sell 1,794 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | Sell | 1,500 | $35,803 |
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | Buy | 4,356 | $8,102 |
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | Sell | 2,611 | $64,339 |
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | Sell | 4,356 | $108,900 |
| 2026-08-04 | van Houte Hans | Chief Financial Officer | Sell | 1,794 | $42,861 |
| 2026-08-04 | van Houte Hans | Chief Financial Officer | Sell | 2,967 | $73,129 |
| 2026-08-03 | Ring Christine | Chief Legal Officer | Buy | 5,787 | $50,463 |
| 2026-08-03 | Ring Christine | Chief Legal Officer | Sell | 16,589 | $382,358 |
| 2026-07-30 | van Houte Hans | Chief Financial Officer | Buy | 2,858 | $0 |
| 2026-07-30 | Ring Christine | Chief Legal Officer | Buy | 3,750 | $0 |
| 2026-07-30 | van Houte Hans | Chief Financial Officer | Buy | 3,750 | $0 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | Buy | 2,858 | $0 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | Buy | 3,750 | $0 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | Buy | 3,572 | $0 |
| 2026-07-30 | Ring Christine | Chief Legal Officer | Buy | 3,572 | $0 |
| 2026-07-30 | van Houte Hans | Chief Financial Officer | Buy | 3,572 | $0 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | Sell | 3,847 | $89,954 |
| 2026-07-30 | Ring Christine | Chief Legal Officer | Sell | 3,847 | $89,954 |
| 2026-07-30 | Ring Christine | Chief Legal Officer | Buy | 2,858 | $0 |
| 2026-07-30 | van Houte Hans | Chief Financial Officer | Sell | 2,845 | $66,524 |
| 2026-07-02 | Ring Christine | Chief Legal Officer | Buy | 5,221 | $9,711 |
| 2026-07-02 | Ring Christine | Chief Legal Officer | Buy | 5,787 | $50,463 |
| 2026-07-02 | Ring Christine | Chief Legal Officer | Sell | 11,008 | $259,366 |
| 2026-06-25 | Ring Christine | Chief Legal Officer | Buy | 13,333 | $96,798 |
| 2026-06-25 | Hansen Gwenn | Chief Scientific Officer | Sell | 5,394 | $107,880 |
Source: SEC Form 4 filings · as of 2026-08-05